It’s possible that GLP-1s may be useful for a range of substance use disorders, including opioid use disorder and nicotine ...

which can help to speed up our understanding of how treatments may work for a new health condition.” GLP-1 receptor agonists may influence the very mechanisms within the brain that regulate ...

Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...

For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that helps balance blood ... “Our long-term goal is to work up to at least 250 minutes weekly of moderate intensity physical ...

A new study adds to a growing body of research suggesting a potential link between popular GLP-1 medications like Ozempic and vision loss.

Embarking on the quest to lose weight can be a risky business. Yo-yo dieting, compulsive binging, muscle wasting and brain ...

If the CMS rule to cover obesity medications is finalized, coverage will increase by other insurers, experts predicted. HHS ...